RED_HUMAN - dbPTM
RED_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID RED_HUMAN
UniProt AC Q13123
Protein Name Protein Red {ECO:0000303|PubMed:10216252}
Gene Name IK
Organism Homo sapiens (Human).
Sequence Length 557
Subcellular Localization Nucleus . Nucleus, nucleoplasm . Chromosome . Cytoplasm, cytoskeleton, spindle pole . Predominantly present throughout the nucleoplasm during prometaphase, metaphase and anaphase. Is also detected in nuclear foci that are not identical with Cajal bod
Protein Description Involved in pre-mRNA splicing as a component of the spliceosome. [PubMed: 28781166 Auxiliary spliceosomal protein that regulates selection of alternative splice sites in a small set of target pre-mRNA species (Probable Required for normal mitotic cell cycle progression]
Protein Sequence MPERDSEPFSNPLAPDGHDVDDPHSFHQSKLTNEDFRKLLMTPRAAPTSAPPSKSRHHEMPREYNEDEDPAARRRKKKSYYAKLRQQEIERERELAEKYRDRAKERRDGVNKDYEETELISTTANYRAVGPTAEADKSAAEKRRQLIQESKFLGGDMEHTHLVKGLDFALLQKVRAEIASKEKEEEELMEKPQKETKKDEDPENKIEFKTRLGRNVYRMLFKSKAYERNELFLPGRMAYVVDLDDEYADTDIPTTLIRSKADCPTMEAQTTLTTNDIVISKLTQILSYLRQGTRNKKLKKKDKGKLEEKKPPEADMNIFEDIGDYVPSTTKTPRDKERERYRERERDRERDRDRDRERERERDRERERERDREREEEKKRHSYFEKPKVDDEPMDVDKGPGSTKELIKSINEKFAGSAGWEGTESLKKPEDKKQLGDFFGMSNSYAECYPATMDDMAVDSDEEVDYSKMDQGNKKGPLGRWDFDTQEEYSEYMNNKEALPKAAFQYGIKMSEGRKTRRFKETNDKAELDRQWKKISAIIEKRKKMEADGVEVKRPKY
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
6Phosphorylation--MPERDSEPFSNPL
--CCCCCCCCCCCCC
54.0820068231
10PhosphorylationERDSEPFSNPLAPDG
CCCCCCCCCCCCCCC
48.5320068231
25PhosphorylationHDVDDPHSFHQSKLT
CCCCCCCCCHHHHCC
29.7923186163
29PhosphorylationDPHSFHQSKLTNEDF
CCCCCHHHHCCHHHH
22.5123186163
30UbiquitinationPHSFHQSKLTNEDFR
CCCCHHHHCCHHHHH
53.40-
38SumoylationLTNEDFRKLLMTPRA
CCHHHHHHHHCCCCC
46.06-
38SumoylationLTNEDFRKLLMTPRA
CCHHHHHHHHCCCCC
46.06-
38UbiquitinationLTNEDFRKLLMTPRA
CCHHHHHHHHCCCCC
46.06-
42PhosphorylationDFRKLLMTPRAAPTS
HHHHHHCCCCCCCCC
15.0221712546
48PhosphorylationMTPRAAPTSAPPSKS
CCCCCCCCCCCCCCC
32.5620068231
49PhosphorylationTPRAAPTSAPPSKSR
CCCCCCCCCCCCCCC
37.4125159151
53PhosphorylationAPTSAPPSKSRHHEM
CCCCCCCCCCCCCCC
42.0528634298
54AcetylationPTSAPPSKSRHHEMP
CCCCCCCCCCCCCCC
58.2324886839
54UbiquitinationPTSAPPSKSRHHEMP
CCCCCCCCCCCCCCC
58.23-
55PhosphorylationTSAPPSKSRHHEMPR
CCCCCCCCCCCCCCC
40.9828634298
83AcetylationKKKSYYAKLRQQEIE
HHHHHHHHHHHHHHH
28.2519608861
83UbiquitinationKKKSYYAKLRQQEIE
HHHHHHHHHHHHHHH
28.2519608861
98AcetylationRERELAEKYRDRAKE
HHHHHHHHHHHHHHH
39.7219608861
98UbiquitinationRERELAEKYRDRAKE
HHHHHHHHHHHHHHH
39.7219608861
112UbiquitinationERRDGVNKDYEETEL
HHHCCCCCCHHHHHH
60.32-
114PhosphorylationRDGVNKDYEETELIS
HCCCCCCHHHHHHHE
19.7828796482
117PhosphorylationVNKDYEETELISTTA
CCCCHHHHHHHEEEC
24.9328796482
121PhosphorylationYEETELISTTANYRA
HHHHHHHEEECCCEE
32.1228060719
122PhosphorylationEETELISTTANYRAV
HHHHHHEEECCCEEC
23.9628060719
123PhosphorylationETELISTTANYRAVG
HHHHHEEECCCEECC
13.2028060719
126PhosphorylationLISTTANYRAVGPTA
HHEEECCCEECCCCH
9.4828796482
137AcetylationGPTAEADKSAAEKRR
CCCHHHCHHHHHHHH
49.3823749302
138PhosphorylationPTAEADKSAAEKRRQ
CCHHHCHHHHHHHHH
33.0021712546
142UbiquitinationADKSAAEKRRQLIQE
HCHHHHHHHHHHHHH
48.42-
151SumoylationRQLIQESKFLGGDME
HHHHHHHHCCCCCCC
43.80-
151SumoylationRQLIQESKFLGGDME
HHHHHHHHCCCCCCC
43.8028112733
151UbiquitinationRQLIQESKFLGGDME
HHHHHHHHCCCCCCC
43.80-
164UbiquitinationMEHTHLVKGLDFALL
CCHHHHHCCHHHHHH
61.18-
173SumoylationLDFALLQKVRAEIAS
HHHHHHHHHHHHHHC
33.39-
1732-HydroxyisobutyrylationLDFALLQKVRAEIAS
HHHHHHHHHHHHHHC
33.39-
173SumoylationLDFALLQKVRAEIAS
HHHHHHHHHHHHHHC
33.39-
173UbiquitinationLDFALLQKVRAEIAS
HHHHHHHHHHHHHHC
33.3921890473
173UbiquitinationLDFALLQKVRAEIAS
HHHHHHHHHHHHHHC
33.3921890473
191AcetylationEEEELMEKPQKETKK
HHHHHHHHCCHHCCC
38.4926051181
191UbiquitinationEEEELMEKPQKETKK
HHHHHHHHCCHHCCC
38.492190698
198UbiquitinationKPQKETKKDEDPENK
HCCHHCCCCCCCCHH
74.00-
205SumoylationKDEDPENKIEFKTRL
CCCCCCHHHHHHHHH
41.78-
205SumoylationKDEDPENKIEFKTRL
CCCCCCHHHHHHHHH
41.78-
205UbiquitinationKDEDPENKIEFKTRL
CCCCCCHHHHHHHHH
41.78-
209UbiquitinationPENKIEFKTRLGRNV
CCHHHHHHHHHCHHH
21.68-
224SumoylationYRMLFKSKAYERNEL
HHHHHCCCCHHCCCC
56.42-
224SumoylationYRMLFKSKAYERNEL
HHHHHCCCCHHCCCC
56.42-
247PhosphorylationVVDLDDEYADTDIPT
EEECCHHHCCCCCCH
19.4427642862
260AcetylationPTTLIRSKADCPTME
CHHHHHCCCCCCCCC
38.0926051181
260UbiquitinationPTTLIRSKADCPTME
CHHHHHCCCCCCCCC
38.09-
270PhosphorylationCPTMEAQTTLTTNDI
CCCCCCCCCCCCHHH
30.7128387310
271PhosphorylationPTMEAQTTLTTNDIV
CCCCCCCCCCCHHHH
15.2728387310
280PhosphorylationTTNDIVISKLTQILS
CCHHHHHHHHHHHHH
15.6628387310
283PhosphorylationDIVISKLTQILSYLR
HHHHHHHHHHHHHHH
19.8023186163
287PhosphorylationSKLTQILSYLRQGTR
HHHHHHHHHHHHCCC
24.6120873877
288PhosphorylationKLTQILSYLRQGTRN
HHHHHHHHHHHCCCC
11.4923186163
303AcetylationKKLKKKDKGKLEEKK
HHCCCCCCCCCCCCC
67.827964201
305AcetylationLKKKDKGKLEEKKPP
CCCCCCCCCCCCCCC
59.477964211
310SumoylationKGKLEEKKPPEADMN
CCCCCCCCCCHHHCC
69.91-
310SumoylationKGKLEEKKPPEADMN
CCCCCCCCCCHHHCC
69.9128112733
310UbiquitinationKGKLEEKKPPEADMN
CCCCCCCCCCHHHCC
69.91-
325PhosphorylationIFEDIGDYVPSTTKT
HHHHHHHCCCCCCCC
14.7318669648
328PhosphorylationDIGDYVPSTTKTPRD
HHHHCCCCCCCCCCH
38.3725159151
329PhosphorylationIGDYVPSTTKTPRDK
HHHCCCCCCCCCCHH
26.6629978859
330PhosphorylationGDYVPSTTKTPRDKE
HHCCCCCCCCCCHHH
36.9425159151
331SumoylationDYVPSTTKTPRDKER
HCCCCCCCCCCHHHH
57.5328112733
331UbiquitinationDYVPSTTKTPRDKER
HCCCCCCCCCCHHHH
57.53-
332PhosphorylationYVPSTTKTPRDKERE
CCCCCCCCCCHHHHH
22.8221712546
382PhosphorylationEEEKKRHSYFEKPKV
HHHHHHHHCCCCCCC
35.2327251275
383PhosphorylationEEKKRHSYFEKPKVD
HHHHHHHCCCCCCCC
15.05-
386AcetylationKRHSYFEKPKVDDEP
HHHHCCCCCCCCCCC
39.9919608861
386SumoylationKRHSYFEKPKVDDEP
HHHHCCCCCCCCCCC
39.9928112733
388SumoylationHSYFEKPKVDDEPMD
HHCCCCCCCCCCCCC
70.17-
388SumoylationHSYFEKPKVDDEPMD
HHCCCCCCCCCCCCC
70.1728112733
394SulfoxidationPKVDDEPMDVDKGPG
CCCCCCCCCCCCCCC
8.0421406390
398AcetylationDEPMDVDKGPGSTKE
CCCCCCCCCCCCHHH
67.8426051181
402PhosphorylationDVDKGPGSTKELIKS
CCCCCCCCHHHHHHH
39.1730576142
403PhosphorylationVDKGPGSTKELIKSI
CCCCCCCHHHHHHHH
34.1630576142
404SumoylationDKGPGSTKELIKSIN
CCCCCCHHHHHHHHH
52.82-
404SumoylationDKGPGSTKELIKSIN
CCCCCCHHHHHHHHH
52.8228112733
404UbiquitinationDKGPGSTKELIKSIN
CCCCCCHHHHHHHHH
52.82-
408SumoylationGSTKELIKSINEKFA
CCHHHHHHHHHHHHC
58.89-
408AcetylationGSTKELIKSINEKFA
CCHHHHHHHHHHHHC
58.8919608861
408SumoylationGSTKELIKSINEKFA
CCHHHHHHHHHHHHC
58.8928112733
408UbiquitinationGSTKELIKSINEKFA
CCHHHHHHHHHHHHC
58.8919608861
409PhosphorylationSTKELIKSINEKFAG
CHHHHHHHHHHHHCC
24.5330108239
413SumoylationLIKSINEKFAGSAGW
HHHHHHHHHCCCCCC
35.71-
413SumoylationLIKSINEKFAGSAGW
HHHHHHHHHCCCCCC
35.71-
413UbiquitinationLIKSINEKFAGSAGW
HHHHHHHHHCCCCCC
35.71-
417PhosphorylationINEKFAGSAGWEGTE
HHHHHCCCCCCCCHH
21.8530108239
423PhosphorylationGSAGWEGTESLKKPE
CCCCCCCHHHCCCHH
15.7520068231
425PhosphorylationAGWEGTESLKKPEDK
CCCCCHHHCCCHHHH
45.3823186163
442PhosphorylationLGDFFGMSNSYAECY
HHHHHCCCCCHHHHE
24.0127251275
444PhosphorylationDFFGMSNSYAECYPA
HHHCCCCCHHHHEEC
20.5727251275
445PhosphorylationFFGMSNSYAECYPAT
HHCCCCCHHHHEECC
15.6326657352
449PhosphorylationSNSYAECYPATMDDM
CCCHHHHEECCHHHC
6.3426657352
452PhosphorylationYAECYPATMDDMAVD
HHHHEECCHHHCCCC
19.3418669648
460PhosphorylationMDDMAVDSDEEVDYS
HHHCCCCCCCCCCHH
40.0820058876
466PhosphorylationDSDEEVDYSKMDQGN
CCCCCCCHHHCCCCC
18.5026074081
467PhosphorylationSDEEVDYSKMDQGNK
CCCCCCHHHCCCCCC
19.6223090842
485PhosphorylationLGRWDFDTQEEYSEY
CCCCCCCCHHHHHHH
37.5617525332
489PhosphorylationDFDTQEEYSEYMNNK
CCCCHHHHHHHHCCC
13.1728796482
490PhosphorylationFDTQEEYSEYMNNKE
CCCHHHHHHHHCCCC
26.0728796482
492PhosphorylationTQEEYSEYMNNKEAL
CHHHHHHHHCCCCHH
10.1328796482
496SumoylationYSEYMNNKEALPKAA
HHHHHCCCCHHCHHH
39.0828112733
501SumoylationNNKEALPKAAFQYGI
CCCCHHCHHHHHHCC
53.87-
501SumoylationNNKEALPKAAFQYGI
CCCCHHCHHHHHHCC
53.8728112733
501UbiquitinationNNKEALPKAAFQYGI
CCCCHHCHHHHHHCC
53.87-
506PhosphorylationLPKAAFQYGIKMSEG
HCHHHHHHCCCCCCC
17.8628152594
509SumoylationAAFQYGIKMSEGRKT
HHHHHCCCCCCCCCC
31.8228112733
509UbiquitinationAAFQYGIKMSEGRKT
HHHHHCCCCCCCCCC
31.82-
516PhosphorylationKMSEGRKTRRFKETN
CCCCCCCCCCCHHCC
26.2222798277
520MethylationGRKTRRFKETNDKAE
CCCCCCCHHCCCHHH
62.91115971385
520UbiquitinationGRKTRRFKETNDKAE
CCCCCCCHHCCCHHH
62.91-
522PhosphorylationKTRRFKETNDKAELD
CCCCCHHCCCHHHHH
49.6723532336
530MethylationNDKAELDRQWKKISA
CCHHHHHHHHHHHHH
57.81115480229
534UbiquitinationELDRQWKKISAIIEK
HHHHHHHHHHHHHHH
38.65-
536PhosphorylationDRQWKKISAIIEKRK
HHHHHHHHHHHHHHH
23.4628112733
5412-HydroxyisobutyrylationKISAIIEKRKKMEAD
HHHHHHHHHHHCCCC
60.14-
541AcetylationKISAIIEKRKKMEAD
HHHHHHHHHHHCCCC
60.1425953088
541SumoylationKISAIIEKRKKMEAD
HHHHHHHHHHHCCCC
60.1428112733
541UbiquitinationKISAIIEKRKKMEAD
HHHHHHHHHHHCCCC
60.14-
543SumoylationSAIIEKRKKMEADGV
HHHHHHHHHCCCCCC
68.4928112733
544SumoylationAIIEKRKKMEADGVE
HHHHHHHHCCCCCCE
46.11-
544SumoylationAIIEKRKKMEADGVE
HHHHHHHHCCCCCCE
46.1128112733
553SumoylationEADGVEVKRPKY---
CCCCCEECCCCC---
49.86-
553AcetylationEADGVEVKRPKY---
CCCCCEECCCCC---
49.8625953088
553SumoylationEADGVEVKRPKY---
CCCCCEECCCCC---
49.8628112733

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources

Oops, there are no upstream regulatory protein records of RED_HUMAN !!

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference

Oops, there are no descriptions of PTM sites of RED_HUMAN !!

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of RED_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
PROF2_HUMANPFN2physical
16169070
CHD3_HUMANCHD3physical
16169070
KAT5_HUMANKAT5physical
16169070
A4_HUMANAPPphysical
21832049
SRS11_HUMANSRSF11physical
22939629
SRSF3_HUMANSRSF3physical
22939629
SRSF5_HUMANSRSF5physical
22939629
SRSF7_HUMANSRSF7physical
22939629
U2AF2_HUMANU2AF2physical
22939629
THOC1_HUMANTHOC1physical
22939629
SRSF1_HUMANSRSF1physical
22939629
U2AF1_HUMANU2AF1physical
22939629
SAP18_HUMANSAP18physical
22939629
TOP1_HUMANTOP1physical
22939629
SEPT7_HUMANSEPT7physical
22939629
SERA_HUMANPHGDHphysical
22939629
SRS10_HUMANSRSF10physical
22939629
SMCA5_HUMANSMARCA5physical
22939629
SP16H_HUMANSUPT16Hphysical
22939629
TPR_HUMANTPRphysical
22939629
SRCAP_HUMANSRCAPphysical
22939629
TOP2B_HUMANTOP2Bphysical
22939629
TR150_HUMANTHRAP3physical
22939629
RS7_HUMANRPS7physical
22939629
WDR18_HUMANWDR18physical
22939629
TRA2A_HUMANTRA2Aphysical
22939629
SAFB2_HUMANSAFB2physical
22939629
ZN326_HUMANZNF326physical
22939629
VTNC_HUMANVTNphysical
22939629
RBM10_HUMANRBM10physical
22365833
U5S1_HUMANEFTUD2physical
22365833
PRP6_HUMANPRPF6physical
22365833
CTBL1_HUMANCTNNBL1physical
22365833
SYF1_HUMANXAB2physical
22365833
SNIP1_HUMANSNIP1physical
22365833
MFAP1_HUMANMFAP1physical
22365833
RED_HUMANIKphysical
22365833
SMU1_HUMANSMU1physical
22365833
THOC1_HUMANTHOC1physical
22365833
F10C1_HUMANFRA10AC1physical
22365833
ZN830_HUMANZNF830physical
22365833
TOE1_HUMANTOE1physical
22365833
TTC14_HUMANTTC14physical
22365833
ZCH10_HUMANZCCHC10physical
22365833
R113A_HUMANRNF113Aphysical
22365833
RACK1_HUMANGNB2L1physical
22365833
KDM1A_HUMANKDM1Aphysical
23455924
CEP70_HUMANCEP70physical
25416956

Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
OMIM Disease
There are no disease associations of PTM sites.
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of RED_HUMAN

loading...

Related Literatures of Post-Translational Modification
Acetylation
ReferencePubMed
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions.";
Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.;
Science 325:834-840(2009).
Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-83; LYS-98; LYS-386 ANDLYS-408, AND MASS SPECTROMETRY.
Phosphorylation
ReferencePubMed
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach.";
Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.;
Anal. Chem. 81:4493-4501(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-460, AND MASSSPECTROMETRY.
"A quantitative atlas of mitotic phosphorylation.";
Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.;
Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-460, AND MASSSPECTROMETRY.
"ATM and ATR substrate analysis reveals extensive protein networksresponsive to DNA damage.";
Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R. III,Hurov K.E., Luo J., Bakalarski C.E., Zhao Z., Solimini N.,Lerenthal Y., Shiloh Y., Gygi S.P., Elledge S.J.;
Science 316:1160-1166(2007).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-485, AND MASSSPECTROMETRY.

TOP